Novo Holdings funds Mutabilis and IBT Vaccines

Novo Holdings has invested $12 million in Mutabilis and IBT Vaccines.

Novo Holdings has invested $12 million in Mutabilis and IBT Vaccines. Mutabilis is a French developer of novel antibacterials against gram-negative infections while Maryland-based IBT Vaccines is focused on vaccines for emerging infectious diseases.

Source: Press Release